GlassScriptPhysician profile
Jeffrey Pampinella
NPI 1447210174
$5,605.82
in general payments reported to CMS, 2019-2025
10 companies · $890 in 2025
The $890 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $953 · 2022: $1,524 · 2023: $1,373 · 2024: $866 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,128.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,822.85 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $1,300.12 | 2021-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Konect Resilia |
| Atricure, INC. | $1,089.52 | 2021-2024 | |
| Medtronic, INC. | $1,059.24 | 2021-2024 | Corevalve Evolut R |
| Baxter Healthcare | $147.28 | 2021-2022 | |
| Ethicon US, LLC | $93.73 | 2022-2023 | Evarrest |
| Getinge USA Sales, LLC | $37.82 | 2021-2022 | |
| Molnlycke Health Care US, LLC | $20.10 | 2023 | Mepilex Border Post-Op, Mepilex Border Post-Op Ag |
| Haemonetics Corporation | $19.38 | 2022 | |
| Angiodynamics, INC. | $15.78 | 2023 | Angiovac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Pampinella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.